Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Clinical Performance of Atypical Contact Lens Powers on Subjects With Astigmatism
This study has been completed.
Sponsored by: Vistakon
Information provided by: Vistakon
ClinicalTrials.gov Identifier: NCT00697190
  Purpose

This study will evaluate the fitting characteristics and physiological response of two toric lenses manufactured by Vistakon.


Condition Intervention
Astigmatism
Device: Acuvue Oasys for Astigmatism
Device: Acuvue Advance for Astigmatism

MedlinePlus related topics: Eye Wear
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind (Subject), Active Control, Crossover Assignment, Safety/Efficacy Study

Further study details as provided by Vistakon:

Primary Outcome Measures:
  • Physical fit [ Time Frame: after 6 hours of wear ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Physiology. [ Time Frame: after 6 hours of wear ] [ Designated as safety issue: Yes ]

Enrollment: 39
Study Start Date: May 2008
Study Completion Date: September 2008
Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
Acuvue Oasys for Astigmatism
Device: Acuvue Oasys for Astigmatism
Contact lens
2: Active Comparator
Acuvue Advance for Astigmatism
Device: Acuvue Advance for Astigmatism
Contact lens

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Able to wear study lenses in parameters available.
  • At least 18
  • understand and sign informed consent
  • willing to follow the protocol
  • achieve at least 6/9 VA OU with study lenses
  • hyperopes: +2.00 to +4.00 with -0.75 D cyl around 180, high myopes: -6.00 to -8.00 with -1.25 D cyl around 180
  • oblique axis: -2.00 to -4.00 with -0.75 D cyl around 45 or 135, have worn SCL's within last 6 months

Exclusion Criteria:

  • Any ocular or systemic disorder which may contraindicate CL wear
  • any topical ocular medication
  • aphakic
  • corneal refractive surgery,
  • corneal distortion from hard CL wear or keratoconus
  • pregnant or lactating
  • grade 2 or worse slit lamp signs
  • infectious disease
  • previous clinical study within 2 weeks
  • don't agree to participate
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00697190

Locations
United Kingdom
Eurolens Research
Manchester, United Kingdom
Sponsors and Collaborators
Vistakon
  More Information

Responsible Party: Vistakon ( John Buch/Principal Research Optometrist )
Study ID Numbers: CR-4523
Study First Received: June 10, 2008
Last Updated: January 8, 2009
ClinicalTrials.gov Identifier: NCT00697190  
Health Authority: United Kingdom: Research Ethics Committee

Study placed in the following topic categories:
Eye Diseases
Refractive Errors
Astigmatism

ClinicalTrials.gov processed this record on January 15, 2009